Doughty Brian 4
4 · Cardiovascular Systems Inc · Filed Feb 11, 2011
Insider Transaction Report
Form 4
Doughty Brian
VP of Marketing
Transactions
- Exercise/Conversion
Common Stock
2011-02-09$7.90/sh+16,175$127,783→ 80,440 total - Exercise/Conversion
Common Stock
2011-02-09$7.90/sh+6,470$51,113→ 86,910 total - Exercise/Conversion
Common Stock
2011-02-09$8.75/sh+3,882$33,968→ 90,792 total - Sale
Common Stock
2011-02-09$10.32/sh−29,697$306,532→ 61,095 total - Exercise/Conversion
Stock Option (right to buy)
2011-02-09−16,175→ 0 totalExercise: $7.90Exp: 2017-06-11→ Common Stock (16,175 underlying) - Exercise/Conversion
Stock Option (right to buy)
2011-02-09−6,470→ 0 totalExercise: $7.90Exp: 2017-08-06→ Common Stock (6,470 underlying) - Exercise/Conversion
Stock Option (right to buy)
2011-02-09−3,882→ 3,882 totalExercise: $8.75Exp: 2019-03-01→ Common Stock (7,764 underlying)
Holdings
- 45,290
Stock Option (right to buy)
Exercise: $8.83Exp: 2016-12-18→ Common Stock (45,290 underlying) - 3,235
Stock Option (right to buy)
Exercise: $8.83Exp: 2017-04-17→ Common Stock (3,235 underlying) - 32,350
Stock Option (right to buy)
Exercise: $12.15Exp: 2017-12-11→ Common Stock (32,350 underlying)
Footnotes (4)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.02 to $10.80 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F2]Fully exercisable.
- [F3]Exercisable: 16,175 on 2/25/10 and 2/25/11.
- [F4]Exercisable: 3,882 on 3/2/10 and 3/2/11.